Why is Colinz Labs falling/rising?

As of 11-Jul, Colinz Laboratories Ltd is experiencing a price increase, currently at 40.19, reflecting a rise of 0.78 or 1.98%. The stock has outperformed its sector by 1.4% today and has shown a consecutive gain over the last two days, with a total return of 4.01% during this period. However, despite this recent uptick, the stock is trading below its moving averages across various time frames, indicating a longer-term downward trend. Over the past year, the stock has generated a significant return of -49.64%, while its profits have only increased by 1%, suggesting that the stock is undervalued compared to its peers. The company has a fair valuation with a Price to Book Value of 2, but its weak long-term fundamentals, including a negative CAGR growth in net sales and a poor EBIT to interest ratio, raise concerns about its profitability and ability to service debt.
In the broader market context, Colinz Laboratories Ltd's short-term performance contrasts with the benchmark, as it has underperformed the Sensex over the past week and month, with returns of -2.07% and -30.39%, respectively. While the stock has shown some positive movement recently, its long-term performance remains below par, as evidenced by its substantial underperformance against the BSE500 over the last three years and one year. This context highlights the challenges the company faces, despite recent gains, as it struggles with weak fundamentals and a significant decline in value over the past year.